R&D
Typewriter Raises $56M to Ditch Viruses From Gene Therapy
Typewriter is betting that a jumping gene borrowed from evolution can insert therapeutic DNA more safely than a virus — delivered by the same lipid nanoparticles that carried the COVID vaccines.